about
Genetic Variants Associated with Colorectal Adenoma Susceptibility.Alerts in electronic medical records to promote a colorectal cancer screening programme: a cluster randomised controlled trial in primary care.Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.Reassessment colonoscopy to diagnose serrated polyposis syndrome in a colorectal cancer screening population.Evaluating the appropriateness of a community pharmacy model for a colorectal cancer screening program in Catalonia (Spain).Analytical and clinical performance of Kroma iT, a compact fully-automated immunochemistry analyzer for fecal occult hemoglobin.Influence of Social Determinants, Lifestyle, Emotional Well-Being and the Use of Unconventional Therapies in Breast Cancer Progression in a Cohort of Women in Barcelona: Protocol for the DAMA Cohort.Patient satisfaction: current and future effects on daily clinical (colonoscopy) practice.An evaluation of the SENTiFIT 270 analyser for quantitation of faecal haemoglobin in the investigation of patients with suspected colorectal cancer.Analysis of participant satisfaction in the Barcelona colorectal cancer screening programme: Positive evaluation of the community pharmacy.[Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies].Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests.Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies.Clinical utility of one versus two faecal immunochemical test samples in the detection of advanced colorectal neoplasia in symptomatic patients.Single reading with computer-aided detection performed by selected radiologists in a breast cancer screening program.Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individualsColonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer ScreeningLa hora de ingesta del polietilenglicol es un factor clave en la tolerancia y eficacia de la preparación del colon en individuos de un programa poblacional de cribado de cáncer colorrectal[Assessment of effectiveness of a plan against tobacco in a universitary hospital][Colorectal cancer screening programs in the population at average risk in the European Union and Spain][Early colorectal cancer detection programs: an integration and quality healthcare challenge]Anxiety and depression in women with breast cancer: Social and clinical determinants and influence of the social network and social support (DAMA cohort)Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-based Screening for Colorectal CancerChanges in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program[Knowledge, clinical skills and interests of medical residents and interns (MIR) when first joining the hospital]
P50
Q35990039-96C2F54E-ED9A-435B-B4FC-9000F546981EQ37028861-74FC970D-6A88-407C-9FF8-275D1673E318Q40091984-3E54EBB7-0747-4DAA-B277-1D5AD9292086Q40541890-5B3CF3E3-F0FF-474B-AB6C-ED767F3CAF29Q41128042-A5B700AC-A55F-4F99-A873-679DC8F097F5Q44668488-56EF0A3A-6321-4684-8A31-89FD3DDCD379Q47286888-D7F7D952-3C5A-4274-AA13-D2DFE781AE87Q48299901-DE56FC65-E846-47AC-96D3-576F3A45D690Q49906941-36AF55D2-F764-4757-AB1E-8D443D4029C7Q50237708-9C6EAB99-375D-4650-BA85-18D8AB9E8275Q50464084-064B0FC9-BCE2-4104-BAAB-5C0AB7AEAD3AQ50468451-C8E4C388-E52D-4922-8F69-6F42ACF6F48AQ50475473-5D189F8B-6770-45E9-88BD-56463B958DF5Q50490585-38AD1930-88E3-4C82-908A-9A9C44F33A63Q50958798-BC35C9FE-6DFB-4C3B-95A1-E75248031599Q53153609-AEA57D91-0837-4486-B48A-CE6A9173899AQ57942530-7F9D29C1-502A-40D2-B56E-5E34EE0B9787Q57942533-57516DB1-C9D2-4700-8E05-2A136A20760CQ59275256-16961CBD-BBAD-487F-ACC0-7609A8B0DEBAQ84004015-88FFC349-313D-4817-907E-7B91818159E7Q84066401-F32E4E88-DAD0-4483-8454-443C9BD631D5Q88079011-9A7BB4BE-FF1B-4780-A620-7ABAC9027311Q89236308-4F82661E-512E-4EEE-B1B3-6B3F9CB1FF8BQ89955756-B2B48580-EF48-457E-8A6C-DB7B5D2E3A61Q90451542-2EA64D52-8101-43FC-B3CB-1DD2D84AF2E3Q94877794-42C2A1A9-7B1A-4F1C-BD61-87690AE8B5C2
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-6811-2215
@en
name
Jaume Grau
@ast
Jaume Grau
@en
Jaume Grau
@es
Jaume Grau
@nl
type
label
Jaume Grau
@ast
Jaume Grau
@en
Jaume Grau
@es
Jaume Grau
@nl
prefLabel
Jaume Grau
@ast
Jaume Grau
@en
Jaume Grau
@es
Jaume Grau
@nl
P106
P1153
35069452700
P31
P496
0000-0002-6811-2215